Fused Pyrimidine-Based Drug Discovery
Elsevier Science Publishing Co Inc (Verlag)
978-0-12-824531-6 (ISBN)
This book focuses on nomenclature, structural chemistry, and chemical and physical properties, along with various approaches for their synthesis. It is ideal for researchers in organic chemistry, both in academic and industrial settings and for postgraduates in chemistry and medicinal chemistry.
Raj Kumar Ph.D. is a Professor of Organic Medicinal Chemistry at Central University of Punjab, Bathinda, India 151001. He obtained his Ph.D. in Medicinal Chemistry (2007) from NIPER, Mohali, India and completed his postdoctoral fellowship (2007-2008) at the University of Maryland Baltimore County (UMBC), Maryland where he coinvented a fused heterocycle RK-33 (Raj Kumar-33) molecule for the treatment of Lung Cancer. His research interests focus on the design and synthesis of novel fused heterocycles of biological importance.
1. Introduction
2. FDA Approved Fused Pyrimidine-Based Drugs
3. Five-Membered Ring Fused Pyrimidine-Based Derivatives (eg. purines) and Biological Properties
4. Six- Membered Ring Fused Pyrimidine-Based Derivatives (eg. Quinazolines, pteridines) and Biological Properties
5. Seven-Membered Ring Fused Pyrimidine-Based Derivatives and Biological Properties
6. Eight-Membered Fused Pyrimidine Derivatives (eg. azocine) and Biological Properties
7. Naturally occurring fused pyrimidine derivatives and Medicinal Attributes
8. Molecular Modeling Studies of Fused Pyrimidine Derivatives at various receptors
| Erscheinungsdatum | 02.09.2022 |
|---|---|
| Reihe/Serie | Heterocyclic Drug Discovery |
| Sprache | englisch |
| Maße | 152 x 229 mm |
| Themenwelt | Naturwissenschaften ► Chemie ► Organische Chemie |
| Technik | |
| ISBN-10 | 0-12-824531-X / 012824531X |
| ISBN-13 | 978-0-12-824531-6 / 9780128245316 |
| Zustand | Neuware |
| Haben Sie eine Frage zum Produkt? |
aus dem Bereich
